Tower Research Capital (TRC)’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Tower Research Capital (TRC)’s Portfolio CHAQ.U Stock Details CHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5	Closed	–	–	6581
2021 Q2	$0	Buy	+5	New	+$53	﹤0.01%	6231
2020 Q4	–	Sell	-200	Closed	-$2K	–	5558
2020 Q3	$2K	Buy	+200	New	+$2.08K	﹤0.01%	4657

Tower Research Capital (TRC)'s CHAQ.U Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 5 shares.

Tower Research Capital (TRC) first reported a position in CHAQ.U in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

Tower Research Capital (TRC) reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 5 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021.
Tower Research Capital (TRC) first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q3 2020 and held it in 2 quarters.
Tower Research Capital (TRC)'s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $2K in Q3 2020.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.